Drug Interactions in Infectious Disease
Language: English
Published by Humana Pr Inc, 2011
- Hardcover
- New

Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
AbeBooks seller since January 6, 2003
Condition: New
US$ 278.17
Quantity: 2 available
Add to basketItem description from seller
3rd edition. 692 pages. 9.75x6.50x1.75 inches. In Stock.
Seller Inventory # x-1617792128
- Title
- Drug Interactions in Infectious Disease
- Author
- Piscitelli, Stephen C (Editor)/ Rodvold, Keith A. (Editor)/ Manjunath P. Pai (Editor)
- Publisher
- Humana Pr Inc
- Publication year
- 2011
- Condition
- Brand New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 1617792128
- ISBN 13
- 9781617792120
- Edition
- 3rd Edition
- Item weight
- 1.18 kilograms
- Series
- Book 28 of 36: Infectious Disease
"Synopsis" may belong to another edition of this title.
From the Back Cover
The revised and up-to-date third edition of Drug Interactions in Infectious Diseases delivers a text that will enhance your clinical knowledge of the complex mechanisms, risks, and consequences of drug interactions associated with antimicrobials, infection, and inflammation. The third edition features five new chapters that cover material not addressed in previous editions. These new chapters describe interactions with a number of drug classes such as non-HIV antiviral, antimalarial, antiparasitic, antihelmintic, macrolide, azalide and ketolide agents. A novel chapter on probe cocktail studies has been included to highlight an important research tool for drug development. These chapters address material that cannot be retrieved easily in the medical literature. The highly acclaimed food-drug interactions as well as the study design and analysis chapters remain definitive references. The newly written drug-cytokine interaction highlights the need for our improved understanding of the complex interrelationship of acute infection, inflammation, and the risk of drug interactions. Informative tables on specific drug-drug interactions are provided throughout the chapters as a quick clinical resource.
The Third Edition of Drug Interactions in Infectious Diseases is a distillation of relevant drug interactions associated with antimicrobials, infection, and inflammation. This concise review of the mechanisms and strategies to manage drug interactions should be valuable to all health care practitioners.
Features
· Definitive reference source of up-to-date information on antimicrobial drug interactions
· Informative tables on the degree of interaction for specific antimicrobial agents
· In-depth discussion of mechanisms and potential mechanistic pathways of interaction
· New chapters on non-HIV antiviral, antimalarial, antiparasitic, and macrolide, azalide and ketolide agents
· New chapter on probe-cocktail studies as a research tool to study drug-drug interactions
· Inclusion of new antimicrobial agents and their associated drug interactions
· First rate chapters on study design and analysis, and drug-food interactions
· A fresh perspective on drug-cytokine interactions
· Authoritative chapter on regulatory considerationsof drug interactions during drug development
· Inclusion of new antimicrobial agents and their associated drug interactions
"About the title" may belong to another edition of this title.
Revaluation Books
Exeter, United Kingdom
AbeBooks seller since January 6, 2003
Shipping rates from United Kingdom to U.S.A.
| Item | 7 to 14 business days | 2 to 3 business days |
|---|---|---|
| First item | US$ 20.04 | US$ 40.08 |
Payment methods
Seller's business information
Edward Bowditch Ltd
Exstowe, Exton
Exeter, United Kingdom EX3 0PP
Terms of sale
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
Shipping terms
Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.